【24h】

The making of a lymphocyte: the choice among disparate cell fates and the IKAROS enigma

机译:淋巴细胞的制作:不同的细胞命名和ikaros enigma之间的选择

获取原文
获取原文并翻译 | 示例
           

摘要

Lymphocyte differentiation is set to produce myriad immune effector cells with the ability to respond to multitudinous foreign substances. The uniqueness of this developmental system lies in not only the great diversity of cellular functions that it can generate but also the ability of its differentiation intermediates and mature effector cells to expand upon demand, thereby providing lifelong immunity. Surprisingly, the goals of this developmental system are met by a relatively small group of DNA-binding transcription factors that work in concert to control the timing and magnitude of gene expression and fulfill the demands for cellular specialization, expansion, and maintenance. The cellular and molecular mechanisms through which these lineage-promoting transcription factors operate have been a focus of basic research in immunology. The mechanisms of development discerned in this effort are guiding clinical research on disorders with an immune cell base. Here, I focus on IKAROS, one of the earliest regulators of lymphoid lineage identity and a guardian of lymphocyte homeostasis.
机译:淋巴细胞分化被设定为产生多数免疫效应细胞,具有对众多异物的能力。这种发育系统的独特性不仅在于它可以产生的细胞功能的巨大多样性,而且还存在其分化中间体和成熟效应细胞在需求时扩大的能力,从而提供终身免疫力。令人惊讶的是,这种发展系统的目标是由一组相对小的DNA结合转录因子进行满足,该转录因子与音乐会一起使用,以控制基因表达的时序和大小,并满足对细胞专业化,扩展和维护的需求。这些促进转录因子经过的细胞和分子机制通过免疫力学的重点是免疫学的基本研究。在这项努力中发现的发展机制正在指导对免疫细胞基础的疾病的临床研究。在这里,我专注于ikaros,淋巴谱系身份的最早调节剂之一和淋巴细胞稳态的监护人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号